Standardization of 13-color high-sensitivity measurable residual disease (MRD) assessment in B-cell lymphoblastic leukemia (B-ALL) treated with novel anti-CD19 immunotherapies

oleh: Prashant Tembhare, Priyanka Dhende, Vruksha Shetty, Simpy Raj, Sitaram Ghogale, Sweta Rajpal, Gaurav Chatterjie, Karisma Girase, Nikhil Patkar, Nilesh Deshpande, Chetan Dhamane, Gaurav Narula, P.G. Subramanian

Format: Article
Diterbitkan: Elsevier 2022-01-01

Deskripsi

No description available for this item.